Second-season Impact of Nirsevimab: Clinical Outcomes of RSV Disease in Patients Immunized During Their First Season
Pediatr Infect Dis J. 2025 Aug 22. doi: 10.1097/INF.0000000000004920. Online ahead of print. ABSTRACT Nirsevimab provides passive immunization against respiratory syncytial virus, yet concerns exist …